Published in

Wiley, Alimentary Pharmacology and Therapeutics, 9(21), p. 1163-1171, 2005

DOI: 10.1111/j.1365-2036.2005.02453.x

Links

Tools

Export citation

Search in Google Scholar

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: Predictive factors for dose reduction and treatment discontinuation

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO